Pennsylvania’s Cannabis Market Could Reach $9 Billion — Here Are The Companies Fighting For Share

Pennsylvania’s medical marijuana program has generated over $9 billion in sales since its launch in 2018, some two years after then-Gov. Tom Wolf signed the Medical Marijuana Act into law.

Since the system’s inception, which currently includes 438,244 active patient certifications, 1,920 approved practitioners, and 192 operational dispensaries, there have been 1,109,727 total patient registrations, according to new data from the state’s Medical Marijuana Advisory Board.

While the market remains primarily medical, it boasts a well-established distribution network with ongoing patient engagement.

Monthly sales remain strong, with operators usually generating over $140 million in sales in recent months, with a peak of approximately $160 million in December 2025, which currently stands as the program’s strongest sales month on record.

Dominated by a mix of large multi-state operators and several state-based or regional brands, the market currently faces declining pricing, a trend that puts pressure on margins.

The price of dry flower decreased from $14.90 per gram in 2021 to $7.60 per gram in early 2026. Over the same period, wholesale prices dropped from $10.65 per gram to $2.85 per gram, the report showed.

Potential legalization of recreational cannabis remains the main catalyst. To that end, lawmakers continue to discuss potential policy reforms, as currently the program allows only patients with qualifying conditions to access the plant.

Pennsylvania Gov. Josh Shapiro recently called the Trump administration’s move to reschedule medical cannabis an “important step,” reported The Center Square. His support for recreational cannabis legalization doesn’t come as a surprise, as he’s been calling on lawmakers to green-light a recreational marijuana program since being elected as governor in 2022.

That position stands in contrast to opposition from Republican leadership in the state, including candidates like Stacy Garrity, who has said she would veto any recreational marijuana legalization bill if elected governor, highlighting how divided Pennsylvania’s political landscape remains on the issue.

Which Operators Could Benefit From Potential Policy Change

• Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF), a company with a significant retail presence and cultivation facilities statewide.
• Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF), which runs many dispensaries across the state and produces several brands.
• Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ), a company known for running Sunnyside dispensaries.
• Green Thumb Industries Inc. (CSE: GTII) (OTCQX: GTBIF), a cannabis operator that manages the RISE chain.
• Ayr Wellness Inc (OTCPK:AYRWF), a multi-state operator that runs multiple retail locations and cultivation operations.
• TerrAscend Corp. (CSE: TER) (OTCQX: TRSSF), a company maintaining a vertically integrated network covering both cultivation and dispensing sites.
• Jushi Holdings Inc. (CSE: JUSH) (OTCQX: JUSHF),a company known for operating Beyond/Hello dispensaries.